Unapproved Depression Drug Remains Available In US In Supplements To Treat Opioid Addiction
Executive Summary
CSPI says FDA has warned companies about tianeptine, which stimulates opioid receptors and may trigger addiction and withdrawal symptoms. But “tianeptine products continue to be widely available in Alabama and online.”